It can be valuable for active individuals, but it is not the best choice for improving overall skin appearance
Both drugs are being developed by Novo Nordisk, likely reflecting a portfolio strategy: CagriSema as the first-to-market injectable combination, and amycretin as a follow-on oral option for patients who prefer pills
Two combination therapies of basal insulin and GLP-1RA are currently available: insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (IGlarLixi), both for once-daily administration [6]
This gradual dose escalation is designed to minimize common adverse effects, particularly gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation
Further, a randomized, double-blind, placebo-controlled trial in 81 healthy children, aged 8 to 14 years, reported that supplementation with a daily multivitamin/mineral for 12 weeks had no effect on various measures of mood (106)
Methods: A retrospective cohort study using data from the TriNetX US Collaborative Network, covering 66 healthcare organizations from May 2022 to April 2024
